Day: iOmx
Needs Review
How Munich biotech startups are fighting cancer
Munich is one of Germany's leading biotech hubs. Research is conducted here on a wide variety of medications and therapies, including cancer. We…
Needs Review
40 million euros in the first round for immunotherapy startup iOmx
With MPM Capital, Sofinnova Partners, Wellington Partners, and Merck Ventures, iOmx Therapeutics AG from Martinsried was able to attract four top investors from…
